Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus

Metadata

Authors/Creators:	Storey, R.F. https://orcid.org/0000-0002-6677-6229 Parker, W.A.E. https://orcid.org/0000-0002-7822-8852
Copyright, Publisher and Additional Information:	© 2016 American Heart Association. This is an author produced version of a paper subsequently published in Circulation. Uploaded in accordance with the publisher's self-archiving policy.
Keywords:	Editorials; diabetes mellitus; pharmacology; platelet activation; prasugrel hydrochloride; ticagrelor
Dates:	Accepted: 28 July 2016 Published (online): 12 September 2016 Published: 13 September 2016
Institution:	The University of Sheffield
Academic Units:	The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Infection, Immunity and Cardiovascular Disease The University of Sheffield > Sheffield Teaching Hospitals
Depositing User:	Symplectic Sheffield
Date Deposited:	16 Nov 2016 12:57
Last Modified:	14 Apr 2017 02:31
Published Version:	https://doi.org/10.1161/CIRCULATIONAHA.116.023835
Status:	Published
Publisher:	American Heart Association
Refereed:	Yes
Identification Number:	https://doi.org/10.1161/CIRCULATIONAHA.116.023835
Related URLs:	Author

CORE (COnnecting REpositories)